Form 0920-0666 CDC 57.1 0920-0666 CDC 57.1 AUR - Pharmacy Electronic Upload - Remdesivir

The National Healthcare Safety Network (NHSN)

57.124_AUR Pharm Electronic Upload Tables_2020_remdesivir

57.124 Antimicrobial Use and Resistence (AUR) - Pharmacy Data

OMB: 0920-0666

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920-0666

Exp. Date: 12/31/22



Antimicrobial Use and Resistance (AUR): Pharmacy Data

Monthly Electronic Upload Specification Tables


These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA).

Table 1. CDA File Descriptors

These data elements will be transmitted with each month’s report.

Variable Name

Description of Variable

orgid

NHSN Facility ID number

location

NHSN location code

month

Denominator month

year

Denominator year

createDate

Date the record was created

createUserID

The user that created the record

version

Version number of the software under which the data was collected

modifyDate

Date the record was last updated

modifyUserID

The user that last modified record

modifyVersion

Version number of the software under which the data was last updated

Table 2. Aggregate Patient Information

These data elements are aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

numDaysPresent

Total number of days present

numTherapyDays

Number of therapy days

numAdmissions

Number of admissions

Table 3. Aggregate Pharmacy Information

These data elements are obtained from the facility’s electronic medication administration record (eMAR) or bar coding medication administration (BCMA) and aggregated to the location and facility wide inpatient level for each month.

Variable Name

Description of Variable

Examples

drugIngredient

Antimicrobial ingredient

(see Table 3a)

routeDrugAdmin

Route of administration

Digestive tract, respiratory tract, intravenous route, intramuscular route

Table 3a. List of Antimicrobials Accepted

This is the list of antimicrobials currently accepted into NHSN as part of the antimicrobial use reporting.

Amantadine

Caspofungin

Cefprozil

Colistimethate

Fidaxomicin

Metronidazole

Peramivir

Telavancin

Amikacin

Baloxavir marboxil

Ceftaroline

Colistin

Fluconazole

Micafungin

Piperacillin

Tetracycline

Amoxicillin

Cefaclor

Ceftazidime

Dalbavancin

Fosfomycin

Minocycline

Piperacillin/

Tazobactam

Tigecycline

Amoxicillin/

Clavulanate

Cefadroxil

Ceftazidime/

Avibactam

Daptomycin

Gemifloxacin

Moxifloxacin

Plazomicin

Tinidazole

Amphotericin B

Cefazolin

Ceftolozane/

Tazobactam

Delafloxacin

Gentamicin

Nafcillin

Polymyxin B

Tobramycin

Amphotericin B liposomal

Cefdinir

Ceftriaxone

Dicloxacillin

Imipenem/

Cilastatin

Nitrofurantoin

Posaconazole

Vancomycin

Ampicillin

Cefepime

Cefuroxime

Doripenem

Isavuconazonium

Omadacycline


Quinupristin/

Dalfopristin

Voriconazole

Ampicillin/

Sulbactam

Cefixime

Cephalexin

Doxycycline

Itraconazole

Oritavancin

Remdesivir

Zanamivir

Anidulafungin

Cefotaxime

Chloramphenicol

Eravacycline

Levofloxacin

Oseltamivir

Rifampin


Arikayce

Cefotetan

Ciprofloxacin

Ertapenem

Linezolid

Oxacillin

Rimantadine


Azithromycin

Cefoxitin

Clarithromycin

Erythromycin

Meropenem

Penicillin G

Sulfamethoxazole/

Trimethoprim


Aztreonam

Cefpodoxime

Clindamycin

Erythromycin/

Sulfisoxazole

Meropenem/ Vaborbactam

Penicillin V

Tedizolid


Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333 ATTN: PRA (0920-0666).

CDC 57.124 v5, 9.4


Page 5 of 5

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
Authorrfp9
File Modified0000-00-00
File Created2021-01-14

© 2024 OMB.report | Privacy Policy